MAXCYTE, INC. Contracts & Agreements

39 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Severance Agreement, dated as of July 1, 2024, by and between the Ali Soleymannezhad and the Registrant
Severance Agreements
MAXCYTE, INC.
Biotechnology
MD
2025
Consulting Agreement, dated February 1, 2025, between Ross Squared Consulting, LLC and the Registrant
Consulting Agreements
MAXCYTE, INC.
Biotechnology
MD
2025
Amended and Restated Severance Agreement, dated as of March 10, 2025, by and between Douglas J. Swirsky, and the Registrant
Severance Agreements
MAXCYTE, INC.
Biotechnology
2025
Resignation Letter, dated December 22, 2024
MAXCYTE, INC.
Biotechnology
2024
Amended and Restated 2022 Plan
MAXCYTE, INC.
Biotechnology
DE
2024
Severance Agreement, between the registrant and Cenk Sumen
Severance Agreements
MAXCYTE, INC.
Biotechnology
MD
2024
Amendment and Restatement of the MaxCyte, Inc. 2022 Equity Incentive Plan
Bonus & Incentive Agreements
MAXCYTE, INC.
Biotechnology
DE
2023
Severance Agreement, dated March 27, 2023, by and between the registrant and Douglas J. Swirsky
Severance Agreements
MAXCYTE, INC.
Biotechnology
MD
2023
Deed of Lease, dated as of May 27, 2021, between Key West MD Owner LLC and Registrant
Lease Agreements
MAXCYTE, INC.
Biotechnology
MD
2023
Severance Agreement, dated March 8, 2017, between the Registrant and Ron Holtz
Severance Agreements
MAXCYTE, INC.
Biotechnology
MD
2023
Amendment to Deed of Lease, dated as of November 16, 2021, between Key West MD Owner LLC and Registrant
Lease Agreements
MAXCYTE, INC.
Biotechnology
2023
MaxCyte, Inc. Form of Stock Option Grant Notice (2022 Equity Incentive Plan), dated as of July 19, 2022
Bonus & Incentive Agreements
MAXCYTE, INC.
Biotechnology
2022
MaxCyte, Inc. Form of RSU Award Grant Notice (2022 Equity Incentive Plan), dated as of July 19, 2022
Bonus & Incentive Agreements
MAXCYTE, INC.
Biotechnology
2022
MaxCyte, Inc. Form of Stock Option Grant Notice (2021 Inducement Plan), dated as of January 1, 2022
Stock Agreements
MAXCYTE, INC.
Biotechnology
2022
Consulting Agreement, by and between the Company and Amanda Murphy, effective as of April 15, 2022
Consulting Agreements
MAXCYTE, INC.
Biotechnology
IL
2022
Separation Agreement, by and between the Company and Amanda Murphy, dated as of May 6, 2022
Separation Agreements
MAXCYTE, INC.
Biotechnology
2022
MaxCyte, Inc. 2022 Equity Incentive Plan
Bonus & Incentive Agreements
MAXCYTE, INC.
Biotechnology
DE
2022
Notice of Termination of Lease Agreement, dated as of June 8, 2021, between ARE-20/22/1300 Firstfield Quince Orchard, LLC and Registrant
Lease Agreements
MAXCYTE, INC.
Biotechnology
2022
Amendment to Deed of Lease, dated as of November 16, 2021, between Key West MD Owner LLC and Registrant
Lease Agreements
MAXCYTE, INC.
Biotechnology
2022
Deed of Lease, dated as of May 27, 2021, between Key West MD Owner LLC and Registrant
Lease Agreements
MAXCYTE, INC.
Biotechnology
MD
2022
Severance Agreement, dated March 8, 2017, between the Registrant and Ron Holtz
Severance Agreements
MAXCYTE, INC.
Biotechnology
MD
2022
MaxCyte, Inc. Inducement Plan
MAXCYTE, INC.
Biotechnology
DE
2022
Description of Certain of Registrant's Securities
MAXCYTE, INC.
Biotechnology
2022
Forms of Grant Notice, Stock Option Agreement under the 2021 Equity Incentive Plan
Bonus & Incentive Agreements
MAXCYTE, INC.
Biotechnology
CA
2021
Form of Underwriting Agreement
Underwriting Agreements
MAXCYTE, INC.
Biotechnology
NY
2021
Form of 2021 Equity Incentive Plan
Bonus & Incentive Agreements
MAXCYTE, INC.
Biotechnology
DE
2021
Form of 2021 Employee Stock Purchase Plan
Stock Agreements
MAXCYTE, INC.
Biotechnology
2021
Form of Indemnification Agreement by and between the Registrant and each director and executive officer
Indemnification Agreements
MAXCYTE, INC.
Biotechnology
DE
2021
Severance Agreement, dated July 20, 2021, between the Registrant and Doug Doerfler
Severance Agreements
MAXCYTE, INC.
Biotechnology
MD
2021
Severance Agreement, dated January 11, 2021, between the Registrant and Brad Calvin
Severance Agreements
MAXCYTE, INC.
Biotechnology
MD
2021
Severance Agreement, dated January 21, 2021, between the Registrant and Amanda Murphy
Severance Agreements
MAXCYTE, INC.
Biotechnology
MD
2021
MaxCyte, Inc. Long-Term Incentive Plan
Bonus & Incentive Agreements
MAXCYTE, INC.
Biotechnology
2021
First Amendment to Sublease, dated as of September 9, 2019, between Novavax, Inc. and the Registrant
Lease Agreements
MAXCYTE, INC.
Biotechnology
2021
First Amendment to Sublease, dated as of September 9, 2019, between Novavax, Inc. and the Registrant
Lease Agreements
MAXCYTE, INC.
Biotechnology
2021
Sublease, dated as of September 9, 2019, between Novavax, Inc. and the Registrant
Lease Agreements
MAXCYTE, INC.
Biotechnology
2021
Eighth Amendment to Lease Agreement, dated as of September 27, 2019, between ARE-20/22/1300 Firstfield Quince Orchard, LLC and the Registrant
Lease Agreements
MAXCYTE, INC.
Biotechnology
2021
Form of Director Stock Option Agreements under the MaxCyte, Inc. Long-Term Incentive Plan
Bonus & Incentive Agreements
MAXCYTE, INC.
Biotechnology
2021
Form of Performance Stock Option Agreements under the MaxCyte, Inc. Long-Term Incentive Plan
Bonus & Incentive Agreements
MAXCYTE, INC.
Biotechnology
2021
Form of New Hire Stock Option Agreements under the MaxCyte, Inc. Long-Term Incentive Plan
Bonus & Incentive Agreements
MAXCYTE, INC.
Biotechnology
2021